Is THAR or DGRO a better dividend investment in 2026?

THAR currently yields 57.64% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: THAR offers higher current income.

What is the dividend yield difference between THAR and DGRO?

THAR has a forward dividend yield of 57.64% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 55.51 percentage points.

Home › Compare › THAR vs DGRO

THAR vs DGRO: Dividend Comparison 2026

THAR yields 57.64% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 THAR wins by $548.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

THAR

● Live price

57.64%

Share price

$3.47

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$579.9K

Annual income

$131,396.64

Full THAR calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — THAR vs DGRO

📍 THAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	THAR	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, THAR + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

THAR pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THAR

Annual income on $10K today (after 15% tax)

$4,899.14/yr

After 10yr DRIP, annual income (after tax)

$111,687.14/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, THAR beats the other by $111,483.18/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THAR + DGRO for your $10,000?

THAR: 50%DGRO: 50%

100% DGRO50/50100% THAR

Portfolio after 10yr

$305.7K

Annual income

$65,818.30/yr

Blended yield

21.53%

📊

Analyst Conviction Gap

Where Wall Street is split right now

THAR

Analyst Ratings

Hold

Consensus: Hold

Altman Z

0.4

Piotroski

2/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THAR buys

DGRO buys

No recent congressional trades found for THAR or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTHARDGRO

Forward yield	57.64% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$579.9K ✓	$31.6K
Annual income after 10y	$131,396.64 ✓	$239.96
Total dividends collected	$477.1K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: THAR vs DGRO ($10,000, DRIP)

Year	THAR Portfolio	THAR Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$16,464	$5,763.69	$11,293	$213.22	+$5.2K → THAR
2	$26,485	$8,868.37	$12,730	$217.32	+$13.8K → THAR
3	$41,671	$13,332.91	$14,326	$221.10	+$27.3K → THAR
4	$64,194	$19,605.90	$16,098	$224.56	+$48.1K → THAR
5	$96,915	$28,226.79	$18,064	$227.74	+$78.9K → THAR
6	$143,525	$39,826.39	$20,246	$230.65	+$123.3K → THAR
7	$208,694	$55,122.07	$22,666	$233.30	+$186.0K → THAR
8	$298,210	$74,907.23	$25,349	$235.73	+$272.9K → THAR
9	$419,119	$100,035.01	$28,325	$237.94	+$390.8K → THAR
10	$579,854	$131,396.64	$31,624	$239.96	+$548.2K → THAR

THAR vs DGRO: Complete Analysis 2026

THAR — Stock

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

Full THAR Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this THAR vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THAR vs SCHD THAR vs JEPI THAR vs O THAR vs KO THAR vs MAIN THAR vs VIG THAR vs NOBL THAR vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.